New eye injection aims to halt leading cause of blindness
Disease control
Recruiting now
This study is testing whether an experimental eye injection called ONL1204 can slow the progression of geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. Researchers will compare different doses and schedules of the injection …
Phase: PHASE2 • Sponsor: ONL Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC